Funding: Another successful funding round, EUR 1.36 million.
Resonandina has successfully completed a EUR 1.36 million funding campaign for Pay per Use MRI’s in Latin America and the Caribbean. The funding was realized by a group of Informal Investors including members of Westfries Kapitaal, Kaasstad Kapitaal and others. Thanks to Peter Vonk, Otto Stoelwinder, Louis Laan and Ted den Ouden.
Good return on investment and offering an impact on health is why our Pay per Use solutions are backed by investors. We are proud to be able to deliver great value to both the customers of our Pay per Use turnkey diagnostic solutions and the investors that support our business and vision.
Word from our CEO Floriaan van Bemmelen: ‘Thank you for trusting us and supporting our mission: improving accessibility of high-end diagnostic services in Latin America’.
Curious? Feel free to contact us for more information about investing.
Other Posts
Health Impact: SDG#3, extra 75.000+ MRI scans/YR; 250+% growth
Enabling extra 75.000+ MRI scans/YR. Our «Pay-per-Use» grows by 250+%. Accessibility. COVID-19 halted progress on universal health coverage and disrupted essential health services by the end of 2021 by 92% in all countries worldwide.
Full-Service: Foundation is the start
Foundation options – Don’t worry, we support you! Some images of the challenges we meet in the field laying the foundation.
Impact: Creating a sustainable hospital adding MRI services – more impact & income.
Find out how our adventure started back in 2010. Incredible! We helped Hospital Arco Iris set up a high quality MRI Service, extending its services and improving access to diagnostics in La Paz.